340 research outputs found
Receptor- G Protein Interactions in the Visual System: A Study of Structures and Mechanisms That Couple the Cytoplasmic Surface of Rhodopsin to the Nucleotide-Binding Pocket of Transducin
The intermolecular interaction between the photoreceptor rhodopsin and the heterotrimeric G protein transducin (Gt) initiates the vertebrate phototransduction cascade. This interaction also serves as a model system for the study of the molecular basis of related G protein-coupled receptor mediated signal transduction systems. Photoactivated rhodopsin (R*) activates Gt by catalyzing the exchange of bound G D P for G T P on its alpha subunit (Ga). The structure of the R*-Gt complex and the mechanism of nucleotide exchange are unknown. We studied the function of the fourth cytoplasmic loop (C4) of rhodopsin in interactions with Gt. Chimeric mutants of rhodopsin were characterized in which regions of C 4 were replaced with amino acid sequences from the beta2 adrenergic receptor or the m l muscarinic receptor. Chimeras in which the amino terminus of C 4 was altered were defective in catalyzing Gt activation. A spectroscopic photoregeneration assay was used to demonstrate that mutants of the amino terminus of C 4 were defective in binding holo-Gt, a peptide derived from the carboxyl terminus of Galpha t, and in certain circumstances a peptide derived from the carboxyl terminus of Gyt. These results suggested that C4 mediated Gt binding and activation and that C4 interacted specifically with the carboxyl termini of G alpha t and possibly Gyt. We next studied how R* induces nucleotide exchange by Gt at a distance. We tested the validityof two longstanding hypotheses: 1) that R* induces opening of the interdomain cleft of G alpha t , and 2) that R * communicates with the nucleotide binding pocket via the a5 helix of Galpha . We developed an expression and assay system to characterize a large number (\u3e50) of site-directed mutants of Galphat designed to test these hypotheses. The mutants were expressed in vitro in rabbit reticulocyte lysate and the kinetics of both basal and R*-catalyzed nucleotide exchange were determined by quantitative analysis of trypsin digest patterns. Mutations in a series of residues at the interface between the two domains of Galphat had only minor effects on the basal and catalyzed activation rates. In contrast, abstract mutations in a cluster of residues on the buried face of the alpha5 helix, 0.7-1.5 nm from the nucleotide, greatly (up to 165-fold) accelerated nucleotide exchange. Mutations of residues on the adjacent solvent-exposed surface of alpha5 disrupted R*-catalyzed activation, as did substitution of alpha5 residues with prolines. These results provided evidence that R* induced nucleotide exchange primarily by perturbing the structure of buried residues on alpha5 and not by opening the interdomain cleft. Structural analysis and biochemical data were used to propose a mechanistic model for receptor-catalyzed G protein activation
Telavancin for hospital-acquired pneumonia: Clinical response and 28-day survival
U.S. Food and Drug Administration draft guidance for future antibiotic clinical trials of bacterial nosocomial pneumonia recommends the use of diagnostic criteria according to American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines and the use of a primary endpoint of 28-day all-cause mortality. The effect of applying these guidelines on outcomes of phase III nosocomial pneumonia studies of telavancin was evaluated in a post hoc analysis. ATS/IDSA criteria were applied in a blind fashion to the original all-treated (AT) group. Clinical cure rates at final follow-up were determined in the refined AT and clinically evaluable (CE) groups (ATS/IDSA-AT and ATS/IDSA-CE, respectively). The exploratory endpoint of 28-day survival was evaluated for the ATS/IDSA-AT group. Noninferiority of telavancin versus vancomycin was demonstrated, with similar cure rates in the ATS/IDSA-AT (59% versus 59%) and ATS/IDSA-CE (83% versus 80%) groups. Cure rates favored telavancin in ATS/IDSA-CE patients where Staphylococcus aureus was the sole pathogen (86% versus 75%). Overall, 28-day survival rates were similar in the telavancin (76%) and vancomycin (77%) groups but lower in telavancin-treated patients with preexisting moderate-to-severe renal impairment (creatinine clearance [CL(CR)] of <50 ml/min). Telavancin should be administered to patients with moderate-to-severe renal impairment only if treatment benefit outweighs the risk or if no suitable alternatives are available
Biasing the quantum vacuum to control macroscopic probability distributions
One of the most important insights of quantum field theory is that
electromagnetic fields must fluctuate. Even in the vacuum state, the electric
and magnetic fields have a nonzero variance, leading to ubiquitous effects such
as spontaneous emission, the Lamb shift, the Casimir effect, and more. These
"vacuum fluctuations" have also been harnessed as a source of perfect
randomness, for example to generate perfectly random photonic bits. Despite
these achievements, many potential applications of quantum randomness in fields
such as probabilistic computing rely on controllable probability distributions,
which have not yet been realized on photonic platforms. In this work, we show
that the injection of vacuum-level "bias" fields into a multi-stable optical
system enables a controllable source of "biased" quantum randomness. We
demonstrate this concept in an optical parametric oscillator (OPO). Ordinarily,
an OPO initiated from the ground state develops a signal field in one of two
degenerate phase states (0 and ) with equal probability. By injecting bias
pulses which contain less than one photon on average, we control the
probabilities associated with the two output states, leading to the first
controllable photonic probabilistic bit (p-bit). We shed light on the physics
behind this process, showing quantitative agreement between theory and
experiment. Finally, we demonstrate the potential of our approach for sensing
sub-photon level fields by showing that our system is sensitive to the temporal
shape of bias field pulses far below the single photon level. Our results
suggest a new platform for the study of stochastic quantum dynamics in
nonlinear driven-dissipative systems, and point toward possible applications in
ultrafast photonic probabilistic computing, as well as the sensing of extremely
weak fields
A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells
Natural killer (NK) cells are cytotoxic innate lymphoid cells that are emerging as a cellular immunotherapy for various malignancies. NK cells are particularly dependent on interleukin (IL)-15 for their survival, proliferation, and cytotoxic function. NK cells differentiate into memory-like cells with enhanced effector function after a brief activation with IL-12, IL-15, and IL-18. N-803 is an IL-15 superagonist composed of an IL-15 mutant (IL-15N72D) bound to the sushi domain of IL-15Rα fused to the Fc region of IgG1, which results in physiological trans-presentation of IL-15. Here, we describe the creation of a novel triple-cytokine fusion molecule, 18/12/TxM, using the N-803 scaffold fused to IL-18 via the IL-15N72D domain and linked to a heteromeric single-chain IL-12 p70 by the sushi domain of the IL-15Rα. This molecule displays trispecific cytokine activity through its binding and signaling through the individual cytokine receptors. Compared with activation with the individual cytokines, 18/12/TxM induces similar short-term activation and memory-like differentiation of NK cells on both the transcriptional and protein level and identica
T-BET and EOMES sustain mature human NK cell identity and antitumor function
Since the T-box transcription factors (TFs) T-BET and EOMES are necessary for initiation of NK cell development, their ongoing requirement for mature NK cell homeostasis, function, and molecular programming remains unclear. To address this, T-BET and EOMES were deleted in unexpanded primary human NK cells using CRISPR/Cas9. Deleting these TFs compromised in vivo antitumor response of human NK cells. Mechanistically, T-BET and EOMES were required for normal NK cell proliferation and persistence in vivo. NK cells lacking T-BET and EOMES also exhibited defective responses to cytokine stimulation. Single-cell RNA-Seq revealed a specific T-box transcriptional program in human NK cells, which was rapidly lost following T-BET and EOMES deletion. Further, T-BET- and EOMES-deleted CD56bright NK cells acquired an innate lymphoid cell precursor-like (ILCP-like) profile with increased expression of the ILC-3-associated TFs RORC and AHR, revealing a role for T-box TFs in maintaining mature NK cell phenotypes and an unexpected role of suppressing alternative ILC lineages. Our study reveals the critical importance of sustained EOMES and T-BET expression to orchestrate mature NK cell function and identity
Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis
: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes several proteins that inhibit host interferon responses. Among these, ORF6 antagonizes interferon signaling by disrupting nucleocytoplasmic trafficking through interactions with the nuclear pore complex components Nup98-Rae1. However, the roles and contributions of ORF6 during physiological infection remain unexplored. We assessed the role of ORF6 during infection using recombinant viruses carrying a deletion or loss-of-function (LoF) mutation in ORF6. ORF6 plays key roles in interferon antagonism and viral pathogenesis by interfering with nuclear import and specifically the translocation of IRF and STAT transcription factors. Additionally, ORF6 inhibits cellular mRNA export, resulting in the remodeling of the host cell proteome, and regulates viral protein expression. Interestingly, the ORF6:D61L mutation that emerged in the Omicron BA.2 and BA.4 variants exhibits reduced interactions with Nup98-Rae1 and consequently impairs immune evasion. Our findings highlight the role of ORF6 in antagonizing innate immunity and emphasize the importance of studying the immune evasion strategies of SARS-CoV-2
The Science Performance of JWST as Characterized in Commissioning
This paper characterizes the actual science performance of the James Webb
Space Telescope (JWST), as determined from the six month commissioning period.
We summarize the performance of the spacecraft, telescope, science instruments,
and ground system, with an emphasis on differences from pre-launch
expectations. Commissioning has made clear that JWST is fully capable of
achieving the discoveries for which it was built. Moreover, almost across the
board, the science performance of JWST is better than expected; in most cases,
JWST will go deeper faster than expected. The telescope and instrument suite
have demonstrated the sensitivity, stability, image quality, and spectral range
that are necessary to transform our understanding of the cosmos through
observations spanning from near-earth asteroids to the most distant galaxies.Comment: 5th version as accepted to PASP; 31 pages, 18 figures;
https://iopscience.iop.org/article/10.1088/1538-3873/acb29
Study of the decay
The decay is studied
in proton-proton collisions at a center-of-mass energy of TeV
using data corresponding to an integrated luminosity of 5
collected by the LHCb experiment. In the system, the
state observed at the BaBar and Belle experiments is
resolved into two narrower states, and ,
whose masses and widths are measured to be where the first uncertainties are statistical and the second
systematic. The results are consistent with a previous LHCb measurement using a
prompt sample. Evidence of a new
state is found with a local significance of , whose mass and width
are measured to be and , respectively. In addition, evidence of a new decay mode
is found with a significance of
. The relative branching fraction of with respect to the
decay is measured to be , where the first
uncertainty is statistical, the second systematic and the third originates from
the branching fractions of charm hadron decays.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-028.html (LHCb
public pages
Measurement of the ratios of branching fractions and
The ratios of branching fractions
and are measured, assuming isospin symmetry, using a
sample of proton-proton collision data corresponding to 3.0 fb of
integrated luminosity recorded by the LHCb experiment during 2011 and 2012. The
tau lepton is identified in the decay mode
. The measured values are
and
, where the first uncertainty is
statistical and the second is systematic. The correlation between these
measurements is . Results are consistent with the current average
of these quantities and are at a combined 1.9 standard deviations from the
predictions based on lepton flavor universality in the Standard Model.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://cern.ch/lhcbproject/Publications/p/LHCb-PAPER-2022-039.html (LHCb
public pages
- …